Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (71-80 of 218) with videos related to

Pageof 22
Sort By:
Nature|August 4, 2017
Angela M. Hartley Brodie (1934-2017)Balkees Abderrahman, V Craig Jordan
JAMA Oncology|November 13, 2018
Moving Precision Oncology Forward Amid Myths and MisconceptionsBalkees Abderrahman, V Craig Jordan
Journal of Surgical Oncology|December 29, 2006
The current status of breast cancer chemoprevention: a star is bornMonica Morrow, V Craig Jordan
European Journal of Cancer (Oxford, England : 1990)|July 14, 2009
Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: the 'personalised' approach?Hiltrud Brauch, V Craig Jordan
Maturitas|October 11, 2011
Progress in endocrine approaches to the treatment and prevention of breast cancerIfeyinwa Obiorah, V Craig Jordan
Molecular Cancer Research : MCR|November 3, 2021
PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast CancerPing Fan, V Craig Jordan
Oncology (Williston Park, N.Y.)|June 16, 2006
Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen. A personal perspectiveV Craig Jordan, Alfred G Knudson
Clinical Breast Cancer|July 16, 2008
Low-dose estrogen therapy to reverse acquired antihormonal resistance in the treatment of breast cancerRamona F Swaby, V Craig Jordan
Cancer Metastasis Reviews|January 29, 2003
Chemoprevention of breast cancer: current and future prospectsSam G Pappas, V Craig Jordan
Mutation Research|August 9, 2005
Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistanceJoan S Lewis, V Craig Jordan
Pageof 22

Showing results (71-80 of 218) with videos related to

Sort By:
Pageof 22
Nature|August 4, 2017
Angela M. Hartley Brodie (1934-2017)Balkees Abderrahman, V Craig Jordan
JAMA Oncology|November 13, 2018
Moving Precision Oncology Forward Amid Myths and MisconceptionsBalkees Abderrahman, V Craig Jordan
Journal of Surgical Oncology|December 29, 2006
The current status of breast cancer chemoprevention: a star is bornMonica Morrow, V Craig Jordan
European Journal of Cancer (Oxford, England : 1990)|July 14, 2009
Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: the 'personalised' approach?Hiltrud Brauch, V Craig Jordan
Maturitas|October 11, 2011
Progress in endocrine approaches to the treatment and prevention of breast cancerIfeyinwa Obiorah, V Craig Jordan
Molecular Cancer Research : MCR|November 3, 2021
PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast CancerPing Fan, V Craig Jordan
Oncology (Williston Park, N.Y.)|June 16, 2006
Improvements in tumor targeting, survivorship, and chemoprevention pioneered by tamoxifen. A personal perspectiveV Craig Jordan, Alfred G Knudson
Clinical Breast Cancer|July 16, 2008
Low-dose estrogen therapy to reverse acquired antihormonal resistance in the treatment of breast cancerRamona F Swaby, V Craig Jordan
Cancer Metastasis Reviews|January 29, 2003
Chemoprevention of breast cancer: current and future prospectsSam G Pappas, V Craig Jordan
Mutation Research|August 9, 2005
Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistanceJoan S Lewis, V Craig Jordan
Pageof 22